What is XOMA Corporation's redeemable NCI?

XOMA Corporation (XOMA) reported redeemable NCI of $20.02M in Q1 2026.

What does redeemable NCI mean?

Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.

XOMA Corporation XOMA Redeemable NCI

Redeemable NCI at other companies

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$12.3M-22.6%

Operating income-$480.0K-108%

Net income$4.5M+88.6%

EPS (diluted)$0.17+183%

Balance sheet

See full

Cash & equivalents$85.6M-5.2%

Total debt$124.7M+9.0%

Total equity$92.9M+9.7%

Total assets$271.9M+27.8%

Cash flow

See full

Operating cash flow$6.1M+178%

CapEx$3.0K-29.4%

Free cash flow-$2.9M+36.0%

Valuation

See full

Market cap$745.16M+159%

Enterprise value$784.29M+151%

P/E22×—

P/S15.4×+8.6×

Profitability

See full

Operating margin10.2%+5.5pp

Net margin69.6%+64.0pp

FCF margin-320%-118pp

Returns & leverage

See full

Return on equity38.1%+35.2pp

Debt / equity1.3×0.0×

Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's redeemable nci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is XOMA Corporation's redeemable NCI?: XOMA Corporation (XOMA) reported redeemable NCI of $20.02M in Q1 2026.
What does redeemable NCI mean?: Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.